Oncology & Hematology
New FDA Draft Guidance Provides Insights on Use of PROs in Oncology Trials
Incorporating patient-reported outcomes (PROs) into clinical trials can help sponsors better understand patients’ symptoms and how a therapy will affect their quality of life, and these insights can be particularly valuable in oncology research. However, there has been a lack...